Immunophage is a clinical-stage biotechnology company dedicated to discovering, developing and commercializing innovative medicines for patients worldwide. We strengthen our R&D pipeline by exploring novel disease pathogenesis, identifying and validating cutting-edge targets, and developing both small-molecule and large-molecule therapeutics. By integrating in-house R&D strengths and strategic cooperation with global biopharmaceutical partners, we strive to advance two innovative drug candidates into clinical trials each year
